Torley Helen

PRESIDENT AND CEO, DirectorHALOZYME THERAPEUTICS, INC. (HALO) · full profile →Form 4 · filed Aug 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.3M
Net Open-Market Flow
-$6.3M
Transactions
17
14 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 19, 2026Sell(S)10K$107.22$1.0M771K
Aug 19, 2026Sell(S)3K$107.77$345K768K
Aug 19, 2026Option exercise(M)20K$18.41$368K788K
Aug 19, 2026Sell(S)7K$106.36$766K781K
Aug 18, 2026Sell(S)6K$103.08$588K782K
Aug 18, 2026Sell(S)9K$104.87$986K768K
Aug 18, 2026Option exercise(M)20K$18.41$368K788K
Aug 18, 2026Sell(S)5K$104.11$510K777K
Aug 17, 2026Option exercise(M)20K$18.41$368K788K
Aug 17, 2026Sell(S)900$98.96$89K787K
Aug 17, 2026Sell(S)500$100.46$50K786K
Aug 17, 2026Sell(S)2K$101.77$214K784K
Aug 17, 2026Sell(S)9K$102.55$923K775K
Aug 17, 2026Sell(S)8K$103.48$776K768K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 19, 2026Option exercise(M)20K$18.41$368K142K
Aug 18, 2026Option exercise(M)20K$18.41$368K162K
Aug 17, 2026Option exercise(M)20K$18.41$368K182K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001159036-26-000108) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.